Literature DB >> 32818438

Back to basics: the outbreak response pillars.

Dale A Fisher1, Gail Carson2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32818438      PMCID: PMC7431160          DOI: 10.1016/S0140-6736(20)31760-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
The Global Outbreak Alert and Response Network (GOARN), with more than 250 technical partner organisations across the world, has undertaken 150 operations in response to disease outbreaks during the past 20 years. We read with interest the Editorial entitled, COVID-19: the worst may be yet to come. GOARN has learned that the worst can be avoided through rapid and robust action to minimise the transmission of severe acute respiratory syndrome coronavirus 2. This prevention and control involves the core pillars of the outbreak response: surveillance and contact tracing, testing, case management, infection prevention and control, epidemiological and outbreak analytics, logistics, risk communication, and community engagement. Lockdowns and border closures are not a desirable long-term strategy; these measures should be used to gain time for building up capacities for a public health response. To this end, the GOARN Steering Committee urges all governments and partners at a local level to (1) engage communities to build trust for evidence-based public health and encourage local ownership of outbreak control response measures; (2) discourage the politicisation of the COVID-19 response because politicisation is counterproductive and leads to poor strategic decisions; (3) leverage in-country expertise of experienced outbreak responders, including GOARN partners and emergency medical teams, because current decisions can be strengthened by expanding the advisory pool; (4) invest in the rapid expansion of the public health workforce for this response; (5) make decisions on the basis of a comprehensive strategy, the latest evidence, and the epidemiological situation (eg, supervised isolation for infectious patients and mandated mask wearing have been shown to improve outcomes), and explain these decisions clearly;2, 3, 4 (6) ensure equitable access to diagnostic tests, therapeutics, and vaccines, which should be allocated according to sound public health criteria and needs; and (7) champion multilateral action and international solidarity. WHO is key to the international response as the organisation offers both a global direction to each nation and tailored technical assistance to responders.
  3 in total

Review 1.  Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US.

Authors:  Wei Lyu; George L Wehby
Journal:  Health Aff (Millwood)       Date:  2020-06-16       Impact factor: 6.301

2.  COVID-19: the worst may be yet to come.

Authors: 
Journal:  Lancet       Date:  2020-07-11       Impact factor: 79.321

3.  Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions.

Authors:  Sheikh Taslim Ali; Lin Wang; Eric H Y Lau; Xiao-Ke Xu; Zhanwei Du; Ye Wu; Gabriel M Leung; Benjamin J Cowling
Journal:  Science       Date:  2020-07-21       Impact factor: 47.728

  3 in total
  7 in total

1.  Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan.

Authors:  Kazuhiro Kamata; Kazuaki Jindai; Nao Ichihara; Hiroki Saito; Hideaki Kato; Hiroyuki Kunishima; Ayumi Shintani; Osamu Nishida; Shigeki Fujitani
Journal:  J Intensive Care       Date:  2021-04-14

Review 2.  COVID-19 response: mitigating negative impacts on other areas of health.

Authors:  Tabitha A Hrynick; Santiago Ripoll Lorenzo; Simone E Carter
Journal:  BMJ Glob Health       Date:  2021-04

Review 3.  Public health measures to reduce the risk of SARS-CoV-2 transmission in Canada during the early days of the COVID-19 pandemic: a scoping review.

Authors:  Julie Polisena; Maria Ospina; Omolara Sanni; Brittany Matenchuk; Rachel Livergant; Sana Amjad; Igor Zoric; Nisrine Haddad; Andra Morrison; Kumanan Wilson; Isaac Bogoch; Vivian A Welch
Journal:  BMJ Open       Date:  2021-03-09       Impact factor: 2.692

Review 4.  Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy.

Authors:  George J Dugbartey; Karl K Alornyo; Bright O Ohene; Vincent Boima; Sampson Antwi; Alp Sener
Journal:  Nitric Oxide       Date:  2022-01-13       Impact factor: 4.427

5.  Strengthening the basics: public health responses to prevent the next pandemic.

Authors:  Victoria Haldane; Anne-Sophie Jung; Chuan De Foo; Mathias Bonk; Margaret Jamieson; Shishi Wu; Monica Verma; Salma M Abdalla; Sudhvir Singh; Anders Nordström; Helena Legido-Quigley
Journal:  BMJ       Date:  2021-11-28

6.  One Health security lessons from a year-long webinar series on international COVID-19 response.

Authors:  Caroline R M Kennedy; Yuri Bruinen de Bruin; Anne-Sophie Lequarré; Rebecca T Ackerman; Jill Luster; Tiffany M Tsang; Kari D McInturff; Cassandra P Carter; Richard Pilch
Journal:  One Health Outlook       Date:  2022-10-08

7.  COVID-19 in Iran: What was done and what should be done.

Authors:  Marzieh Nojomi; Maziar Moradi-Lakeh; Farshad Pourmalek
Journal:  Med J Islam Repub Iran       Date:  2021-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.